Literature DB >> 20812766

Reflections on attribution and decisions in pharmacovigilance.

Ola Caster, I Ralph Edwards.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20812766     DOI： 10.2165/11532460-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  8 in total

1.  A model for the future conduct of pharmacovigilance.

Authors:  Patrick C Waller; Stephen J W Evans
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003 Jan-Feb       Impact factor: 2.890

2.  THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION?

Authors:  A B HILL
Journal:  Proc R Soc Med       Date:  1965-05

3.  First, catch your signal!

Authors:  I Ralph Edwards; Marie Lindquist
Journal:  Drug Saf       Date:  2010-04-01       Impact factor: 5.606

Review 4.  Anecdotes that provide definitive evidence.

Authors:  Jeffrey K Aronson; Manfred Hauben
Journal:  BMJ       Date:  2006-12-16

5.  Guidelines for submitting adverse event reports for publication.

Authors:  William N Kelly; Felix M Arellano; Joanne Barnes; Ulf Bergman; Ralph I Edwards; Alina M Fernandez; Stephen B Freedman; David I Goldsmith; Kui A Huang; Judith K Jones; Rachel McLeay; Nicholas Moore; Rosie H Stather; Thierry Trenque; William G Troutman; Eugene van Puijenbroek; Frank Williams; Robert P Wise
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 6.  Defining 'signal' and its subtypes in pharmacovigilance based on a systematic review of previous definitions.

Authors:  Manfred Hauben; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

7.  Quality criteria for early signals of possible adverse drug reactions.

Authors:  I R Edwards; M Lindquist; B E Wiholm; E Napke
Journal:  Lancet       Date:  1990-07-21       Impact factor: 79.321

8.  A reevaluation of X-irradiation-induced phocomelia and proximodistal limb patterning.

Authors:  Jenna L Galloway; Irene Delgado; Maria A Ros; Clifford J Tabin
Journal:  Nature       Date:  2009-06-24       Impact factor: 49.962
  8 in total
  5 in total

1.  Adverse drug effects and their clinical management: a personal view.

Authors:  I Ralph Edwards
Journal:  Drug Saf       Date:  2014-06       Impact factor: 5.606

2.  Have Current Systems of Pharmacovigilance Had Their Day?: THE "CON" SIDE.

Authors:  Christine M Bond
Journal:  Can J Hosp Pharm       Date:  2020-04-01

3.  Causality Assessment in Pharmacovigilance: Still a Challenge.

Authors:  I Ralph Edwards
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

4.  Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance system.

Authors:  Preciosa M Coloma; Martijn J Schuemie; Gianluca Trifirò; Laura Furlong; Erik van Mulligen; Anna Bauer-Mehren; Paul Avillach; Jan Kors; Ferran Sanz; Jordi Mestres; José Luis Oliveira; Scott Boyer; Ernst Ahlberg Helgee; Mariam Molokhia; Justin Matthews; David Prieto-Merino; Rosa Gini; Ron Herings; Giampiero Mazzaglia; Gino Picelli; Lorenza Scotti; Lars Pedersen; Johan van der Lei; Miriam Sturkenboom
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

Review 5.  Causality Assessment of Olfactory and Gustatory Dysfunction Associated with Intranasal Fluticasone Propionate: Application of the Bradford Hill Criteria.

Authors:  Chandrashekhar S Muganurmath; Amy L Curry; Andrew H Schindzielorz
Journal:  Adv Ther       Date:  2018-02-02       Impact factor: 3.845
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.